In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I - Test2 - elhamkhani - TriplyDB

In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

http://www.wikidata.org/entity/Q24679571

about

Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia Use of ferrous iron by metallo-β-lactamases Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I).Recent developments in carbapenems.New insertion sequence elements in the upstream region of cfiA in imipenem-resistant Bacteroides fragilis strains Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re In vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents.Future directions in antimicrobial chemotherapy.In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.In vitro activity and beta-lactamase stability of LJC 10,627 Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities.Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli.Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus.In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.Meropenem pharmacokinetics and penetration into an inflammatory exudate.Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.Meropenem: a new carbapenem antimicrobial.Plasma pharmacokinetics and urine concentrations of meropenem in ewes.Effect of meropenem on the intestinal microflora.Determination of meropenem in plasma by high-performance liquid chromatography and a microbiological method.History of antibiotics: from fluoroquinolones to daptomycin (Part 2).Outcome evaluation of an intervention to improve the effective and safe use of meropenem.Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli.Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections.Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia.Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338.Automatic phylogenetic classification of bacterial beta-lactamase sequences including structural and antibiotic substrate preference information.Pharmacodynamic effects of meropenem on gram-negative bacteria.Comparative activity of meropenem (SM-7338) against major respiratory pathogens and amikacin-resistant nosocomial isolates.

P2860

Q24533461-20CDB22A-6AB0-47B8-A5B0-D25E05BAAEA7 Q27725877-41CEFC67-F487-4ADA-A24B-39B6B24EAD38 Q34105432-B7B79F4D-834D-44CF-A9B7-53D90310EB73 Q34581503-15B58F1D-35FD-4CDF-B851-C2C05855BBF8 Q34734963-CFE5D346-FE95-4FC0-948A-8A369B5870C7 Q35124179-C0A13136-0CF9-4D3A-BF66-4202802B63FD Q35278735-4B1D6E19-29B4-4F75-9429-7FC72FC39EA8 Q35530705-F157B841-A58E-4BDA-84A2-8CB69ADF0568 Q35807882-65C926D3-5D77-4462-A244-F4C5D2CE8466 Q35808464-7E85DD8A-78A8-497C-A4BE-ABA2B11E52D4 Q35884855-2681448F-B840-4818-9B92-5D69C24A242A Q35897020-C94DCA2C-650E-4186-B5F3-B944D1F36E42 Q36753240-589A7FB5-650E-4B71-8531-3CE43DFA47B4 Q36757229-2FF1A6D9-3267-42A5-BE36-21FA11818B4F Q37193964-E35761EB-EBEE-421D-803F-032A29AA2757 Q37230830-952C3381-28F9-4484-AF62-256FCB87C6EB Q39779531-11A353A3-1F9D-4551-A032-FC8763FAABC0 Q39815567-C71BC90B-F05F-4B4A-8B69-7003CBE3DDD4 Q39816098-A43453D8-412B-4DEF-943C-979549A4FBD5 Q39816570-C81D8430-2FBF-4991-8AA6-99B92C696FE7 Q39881769-87D86007-09BB-4D05-BBCA-C764D0DD8318 Q40088934-C2F91274-F37B-401C-BD27-FFEF27498652 Q40558157-AF00B31B-E28C-48D9-9C41-B572D961C014 Q44783360-45FFE9C8-43EC-40AF-8B57-21295ADAB547 Q46498880-4162C33D-03D9-4ACF-AACA-D586CB5095C6 Q47337023-EA587C60-8D93-42D8-AAAB-55CAF0FD2930 Q48202873-89D67B48-571B-469F-A9B3-231C0C73B43B Q50696325-8EE73B40-BA2D-49FE-8976-F06D66E8F8C6 Q53797688-161169D1-E818-4DE4-A316-60DC3773A6A0 Q53979811-17B00FE7-6798-48BB-8385-5B05C54B93E5 Q54257557-357189F3-48E0-4054-B093-5F7FFBFB3D69 Q54295056-AB21624C-78C9-470E-955E-0CC6E87101E6 Q54338470-C2CE379B-98F2-4AB5-AD32-85DAE63CE38A Q54344333-7DAF880E-BB1C-424F-A826-BD7DB449C729 Q54393142-899FD8AB-2C1A-4E1B-BE22-A09268A5AAEB Q54613484-51AA8F85-4212-4493-9256-AA6D328C222B Q54685330-5416CF1D-2026-4078-944C-AB5808DB5ED8

P2860

In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

http://www.wikidata.org/entity/Q24679571

description

1989 nî lūn-bûn

@nan

1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

In vitro antibacterial activit ...... tability to dehydropeptidase I

@ast

In vitro antibacterial activit ...... tability to dehydropeptidase I

@en

In vitro antibacterial activit ...... tability to dehydropeptidase I

@nl

type

label

In vitro antibacterial activit ...... tability to dehydropeptidase I

@ast

In vitro antibacterial activit ...... tability to dehydropeptidase I

@en

In vitro antibacterial activit ...... tability to dehydropeptidase I

@nl

prefLabel

In vitro antibacterial activit ...... tability to dehydropeptidase I

@ast

In vitro antibacterial activit ...... tability to dehydropeptidase I

@en

In vitro antibacterial activit ...... tability to dehydropeptidase I

@nl

P1433

Q24679571-6EC2AADB-06FD-4738-AC6B-B97A3D64DEEA

P1476

Q24679571-B4EB1227-688C-4B98-85D6-FE0D4430BB3D

P2093

Q24679571-15080F8C-8DCB-478B-9BF5-7B5F4CBBABD3

Q24679571-1678E35C-1837-4A81-B292-28EB0C587FF4

Q24679571-17E06694-78EC-4AB6-BE69-4070C6EB64D4

Q24679571-844AC9DA-75F0-4E8A-A28E-D81A05B15D5C

Q24679571-E90E0020-0E25-4821-98E0-36AA01401E26

Q24679571-F627BBEA-92D3-4A91-B24D-53BD40CAAF3D

P2860

Q24679571-0E783D58-72EC-4071-91BC-837AA9293242

Q24679571-4AA19D12-A271-4BD4-904D-1E9BE5F36EBA

Q24679571-5B89DC03-37FF-4E3A-B177-AC40F4C49E7F

Q24679571-91DF92A9-4E54-45E7-9DAE-F9EB94BA5A98

Q24679571-DE4A3764-CB42-47AE-838D-0C9732C9920E

P304

Q24679571-F3A2E2A3-ADBF-458A-9FB0-35A73EB66BA3

P31

Q24679571-94E0805F-A4AA-4D59-B2F1-568DC52CDCAA

P3181

Q24679571-F716351D-FF61-4854-B511-1DDCE78EEFB0

P356

Q24679571-4CA32695-DDD7-465D-A654-AD6BD8648736

P407

Q24679571-395BA319-44F5-4F50-A26C-AA0231812EF3

P433

Q24679571-33D4F613-263F-48E9-8DB6-62E4B155C807

P478

Q24679571-C84B9E10-D6CA-433F-B726-7B20BCAEA44A

P577

Q24679571-0D10AFF0-0B57-4C82-95B3-FAE226F91C67

P5875

Q24679571-00768D89-A7A1-4F2C-8B35-5228552FFC0C

P698

Q24679571-BF859E43-143D-4CFE-BD2D-8F00FC0E53EE

P921

Q24679571-E4C660F6-4B80-4C0C-95AC-0AC66656C0D0

P932

Q24679571-C0D8BCB4-8FCA-416B-855C-6C1CFBDD9B1E

P3181

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro antibacterial activit ...... tability to dehydropeptidase I

@en

P2093

A J Grindey

http://www.w3.org/2001/XMLSchema#string

C Wannop

http://www.w3.org/2001/XMLSchema#string

E S Withnell

http://www.w3.org/2001/XMLSchema#string

J R Edwards

http://www.w3.org/2001/XMLSchema#string

K Nairn

http://www.w3.org/2001/XMLSchema#string

P J Turner

http://www.w3.org/2001/XMLSchema#string

P2860

Thienamycin: development of imipenen-cilastatin

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.

[Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins]

Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.

Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

P304

215-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4391858

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.33.2.215

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

1989-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20499751

http://www.w3.org/2001/XMLSchema#string

P698

2655530

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

171460

http://www.w3.org/2001/XMLSchema#string